HERON THERAPEUTICS, INC. /DE/ Payments for (Proceeds from) Investments
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Payments for (Proceeds from) Investments of -$52.69 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromInvestments · last filed 2017-08-09
- HERON THERAPEUTICS, INC. /DE/ payments for (proceeds from) investments for the quarter ending 2017-06-30 was -$27.30M.
- HERON THERAPEUTICS, INC. /DE/ payments for (proceeds from) investments for the quarter ending 2017-03-31 was -$25.39M.
- HERON THERAPEUTICS, INC. /DE/ payments for (proceeds from) investments for the quarter ending 2016-12-31 was -$5.50M.
- HERON THERAPEUTICS, INC. /DE/ payments for (proceeds from) investments for the quarter ending 2016-09-30 was -$12.70M.
- HERON THERAPEUTICS, INC. /DE/ payments for (proceeds from) investments for fiscal 2016 was -$61.33M.
| Period end | Payments for (Proceeds from) Investments 3 month | Payments for (Proceeds from) Investments 6 month | Payments for (Proceeds from) Investments 9 month | Payments for (Proceeds from) Investments 12 month |
|---|---|---|---|---|
| 2017-06-30 | -$27.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$52.69M 10-Q · filed 2017-08-09 | -$58.19M derived: sum of 3 quarters · filed 2017-08-09 | -$70.89M derived: sum of 4 quarters · filed 2017-08-09 |
| 2017-03-31 | -$25.39M 10-Q · filed 2017-05-10 | -$30.89M derived: sum of 2 quarters · filed 2017-05-10 | -$43.59M derived: sum of 3 quarters · filed 2017-05-10 | -$63.23M derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-12-31 | -$5.50M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$18.20M derived: sum of 2 quarters · filed 2017-02-23 | -$37.84M derived: sum of 3 quarters · filed 2017-08-09 | -$61.33M 10-K · filed 2017-02-23 |
| 2016-09-30 | -$12.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$32.34M derived: sum of 2 quarters · filed 2017-08-09 | -$55.83M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | -$19.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$43.13M 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | -$23.49M 10-Q · filed 2017-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |